Project: Innovative Multifaceted Platform for Antimicrobials Commercialisation Transformation 2
| Acronym | IMPACT2 (Reference Number: 12589) |
| Duration | 01/09/2018 |
| Project Topic | BioVersys (BV), BioSystems Technology (BST) and Voxcan (VX) will produce a solution to transform antimicrobial drug discovery through a seamless platform for effective in vitro and real-time in vivo drug candidate screening and target validation. It will reduce drug candidate failures by streamlining pre-clinical evaluation directly in clinically relevant strains prior to testing candidates in expensive and time-consuming mammalian infection models, bridging the pharmaceutical "Valley of Death". |
| Network | Eurostars 2 |
| Call | Eurostars Cut–off 9 |
Project partner
| Number | Name | Role | Country |
|---|---|---|---|
| 1 | BioVersys | Coordinator | Switzerland |
| 2 | BioSystems Technology | Partner | United Kingdom |
| 3 | Voxcan | Partner | France |